Expression of nectin-4 in papillary renal cell carcinoma

BACKGROUND: Nectin-4 contributes to tumor proliferation, lymphangiogenesis and angiogenesis in malignant tumors and is an emerging target in tumor therapy. In renal cell carcinoma (RCC) VEGF-directed tyrosine kinase inhibitors and checkpoint inhibitors are currently treatments of choice. Enfortumab...

Descripción completa

Detalles Bibliográficos
Autores principales: Zschäbitz, Stefanie, Mikuteit, Marie, Stöhr, Christine, Herrmann, Edwin, Polifka, Iris, Agaimy, Abbas, Trojan, Lutz, Ströbel, Philipp, Becker, Frank, Wülfing, Christian, Barth, Peter, Stöckle, Michael, Staehler, Michael, Stief, Christian, Haferkamp, Axel, Hohenfellner, Markus, Duensing, Stefan, Macher-Göppinger, Stephan, Wullich, Bernd, Noldus, Joachim, Brenner, Walburgis, Roos, Frederik C., Walter, Bernhard, Otto, Wolfgang, Burger, Maximilian, Schrader, Andres Jan, Hartmann, Arndt, Erlmeier, Franziska, Steffens, Sandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500133/
https://www.ncbi.nlm.nih.gov/pubmed/36136143
http://dx.doi.org/10.1007/s12672-022-00558-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500133/
https://www.ncbi.nlm.nih.gov/pubmed/36136143
http://dx.doi.org/10.1007/s12672-022-00558-2

Ejemplares similares